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【論文審査】Review of the thesis
In	 the	 thesis,	 “Regime of gene silencing: Efficient siRNA delivery into cancer cells using 
nanocapsules”,	Ms.	Archana	Raichur	 presents	 siRNA	delivery	 into	 cancer	 cells	 by	 using	
polymeric	 hollow	 nanocapsules	（NPs）.	 She	 used	 siRNA	 to	 downregulate	 the	 MYC	
protooncogene	in	cancer	cells	using	functionalized	PLGA	NPs.	These	siRNA	encapsulated	
hollow	PLGA	nanoparticles	were	 functionalized	by	 cell	 penetrating	peptide	 and	peptide	
nucleic	acid	for	enhanced	cellular	uptake.	The	thesis	is	divided	into	six	chapters.
In	chapter	one,	“History of techniques used in siRNA delivery in the field of nanomedicine”	
is	discussed.	The	potential	ability	of	siRNA	to	silence	abnormal	gene	expression	created	a	
new	horizon	in	the	field	of	gene	therapy.	Until	now,	different	types	of	nanoparticles	like	
organic,	 inorganic	 and	 hybrid	 nanoparticles	 were	 used	 in	 siRNA	 delivery.	 These	
nanoparticles	 have	 proved	 effective	 in	 siRNA	 delivery.	 The	 major	 hindrances	 in	 the	
application	 of	 siRNA	 delivery	 are	 its	 stability	 and	 its	 effective	 in vivo	 delivery.	Apart	
from	these,	renal	clearance,	uptake	by	phagocytic	cells,	aggregation	with	serum	proteins	
and	enzymatic	degradation	are	certain	other	factors	that	affect	systemic	siRNA	delivery.	
To	 overcome	 these	 barriers,	 certain	 techniques	 like	 layer-by-layer	（LBL）	 assembly,	
encapsulation	and	PEGylation	techniques	are	used	for	enhanced	siRNA	delivery.
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6In	chapter	two,	Archana	discusses	the	“Techniques for characterization of nanomaterials.”	In	
this	chapter	she	discussed	the	principle	of	the	instrumentation	used	for	characterization	
of	 the	 nanomaterials	 in	 her	 research.	 The	 basic	 understanding	 and	 analysis	 of	 the	
physiochemical	 properties	 of	 the	 nanomaterials	 are	 essential	 to	 acquire	 insight	 into	 the	
unique	 properties	 of	 nano-scaled	 materials	 when	 compared	 to	 bulk	 counterparts.	 In	
addition	 to	 their	 material	 properties,	 the	 application	 in	 bio-nano	 interface	 was	 also	
analyzed.	She	has	used	electron	microscopy,	spectroscopic	studies	and	molecular	biology	
techniques	for	characterization	of	the	nanoparticles.
In	chapter	three,	“Importance of gene therapy and use of polymeric nanoparticles in siRNA 
delivery”	is	described.	RNAi	（RNA	interference）	is	a	fundamental	pathway	in	eukaryotic	
cells	by	which	sequence	of	specific	siRNA	is	able	to	cleave	complementary	mRNA.	RNAi	
is	triggered	by	the	presence	of	long	strands	of	double	stranded	siRNA,	which	are	cleaved	
into	 fragments	 by	 enzyme	 DICER.	 In	 practice,	 these	 double	 stranded	 RNA	 are	
synthetically	produced	and	 introduced	directly	 inside	the	nucleus	of	cell.	Therefore,	 the	
use	of	siRNA	will	not	affect	the	other	genes	and	their	functions.	Owing	to	this	potential,	
siRNA	delivery	technique	is	the	future	of	upcoming	scientific	and	therapeutic	studies.	It	
is	 one	 of	 the	 reliable	 and	 effective	 tools	 that	 can	 be	 used	 for	 treatment	 of	 various	
diseases.	 The	 in vivo	 delivery	 of	 siRNA	 in	 its	 active	 form	 is	 complex	 and	 multistep	
process.	The	therapeutic	siRNAs	have	to	overcome	RNase	mediated	degradation	and	renal	
clearance,	 and	 enter	 the	 target	 cells	 by	 endocytosis,	 followed	 by	 nuclear	 uptake.	
Nanotechnology	has	been	adopted	to	overcome	these	barriers	faced	by	unprotected	siRNA	
when	 administered	 intravenously.	 Also,	 nanotechnology	 enhances	 siRNA	 delivery	 to	
become	more	efficient.	Polymeric	nanoparticles	are	biodegradable,	biocompatible	and	have	
the	capacity	to	encapsulate	siRNA.	Therefore	polymeric	nanoparticles	are	widely	used	in	
siRNA	delivery	 oriented	 research.	The	 application	 of	 nanotechnology	 and	 gene	 delivery	
together	conquers	many	hurdles	in	curing	various	diseases.	The	chapter	three	deals	with	
the	significance	of	gene	delivery	in	cancer	cells	and	polymeric	nanoparticles	used	in	gene	
delivery.	The	need	for	siRNA	delivery	is	also	highlighted	in	this	chapter.
In	 chapter	 four,	 “Hollow polymeric PLGA nanocapsules synthesis by solvent emulsion 
evaporation method for enhanced drug encapsulation and release efficiency”	 is	 reported.	
Nano-hollow	polymer	shells	have	captured	the	attention	of	many	researchers	in	the	field	
of	pharmaceutical	and	medical	therapeutics.	In	the	field	of	controlled	drug/gene	release;	
nano-capsules	in	colloidal	solutions;	i.e.,	particles	with	hollow	piths	play	an	important	role	
in	 cargo	 encapsulation.	 These	 NPs	 are	 synthesized	 using	 a	 variety	 of	 procedures	 like	
emulsion	polymerization,	phase	separation,	crosslinking	of	micelles,	inner	core	etching	and	
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self-assembly.	The	 present	work	 proposes	 a	 novel	 route	 to	 prepare	 hollow	PLGA	NPs	
（HNPs）,	 which	 showed	 increased	 drug-encapsulation	 and	 release	 efficiency.	 Simple	
emulsion	solvent	evaporation	technique	was	adopted	to	synthesize	nano-	hollow	shells.	The	
hollow	 characteristics	 of	NPs	were	 studied	 using	SEM,	TEM	and	Confocal	microscopy	
analyses.	The	particle	size	was	analyzed	by	DLS.	Drug	（paclitaxel）	loading,	encapsulation	
and	release	efficiency	in	in vitro	were	assessed	by	ultraviolet	spectroscopy.	The	developed	
NPs	 were	 hollow	 and	 spherical	 in	 shape	 with	 approximately	 80nm	 in	 size.	 The	 drug	
encapsulation	efficiency	is	99.4％	and	drug	was	released	in	controllable	manner	during	in 
vitro	analysis.	Hollow	NPs	have	great	efficiency	 for	gene	and	drug	release	as	compared	
with	non-hollow	NPs.	Using	targeted	moiety	and	due	to	 their	 tailored	porous	structure,	
high	 cargo	 loading	 and	 encapsulating	 efficiency,	 zero	 order	 drug	 release	 kinetics	 and	
material	 reliability	 have	 been	 obtained.	 In	 chapter	 four,	 she	 reports	 the	 synthesis	 of	
PLGA	hollow	nanoparticles	which	released	 the	drug	 in	controllable	manner	 that	can	be	
used	as	a	nano	vehicle	to	deliver	gene	and	drug	in	cell	organelles.	The	synthesis	of	hollow	
PLGA	NPs	by	the	single	emulsion	solvent	method	is	an	economical	way	of	synthesis	with	
enhanced	drug	encapsulation	and	release	efficiency.
In	chapter	five,	she	describes	“Strategist PLGA nanocapsules to deliver siRNA for inhibition 
of carcinoma and neuroblastoma cell lines by knockdown of MYC proto-oncogene using CPP 
and PNA”.	 RNA	 interference	 and	 the	 therapeutic	 applications	 using	 siRNA	 were	
discovered	more	than	10	years	ago	and	currently	are	used	in	various	applications	including	
in	 the	therapeutic	 field.	However,	 the	research	 in	 this	 field	 is	still	 in	 its	 infancy.	Many	
challenges	like	safe	delivery	of	targeted	siRNA	to	nucleus	and	cytosol	of	cancerous	cells	
without	 compromising	 the	 activity	 of	 siRNA	 need	 to	 be	 addressed.	 She	 overcame	 this	
hurdle	with	the	help	of	nanotechnology	using	PLGA	hollow	nanoparticles	and	suppressing	
the	oncogene	of	MYC	transcription	factors	by	using	anti	myc-siRNAs	in	human	cancer	cell	
lines.	 siRNA	 was	 encapsulated	 in	 PLGA	 hollow	 nanoparticles.	 These	 spherical	 PLGA	
hollow	nanoparticles	（PLGAHNPs）	of	size	70	nm	had	high	efficiency	of	gene	release	at	
pH	4.2	under	 in vitro	 conditions.	Cell	penetrating	peptide	（CPP）-	Tat	peptide	（TAT）	
and	 peptide	 nucleic	 acid-	 nucleolus	 localizing	 signal	（PNA-NLS）	 were	 used	 for	
functionalizing	 the	nanoparticles	without	affecting	 the	 therapeutic	activity	of	 siRNA.	 In	
this	 study,	 she	 used	 layer-by-layer	 technique	 to	 formulate	 functionalized	 nanoparticles.	
The	advantages	of	LBL	technique	include	ease	of	preparation,	versatility,	and	capability	
of	incorporating	controlled	high	loadings	of	different	types	of	biomolecules	in	layers.	By	
taking	 advantage	 of	 this	 technique,	 she	 incorporated	 layers	 of	 TAT	 peptide	 and	PNA-
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8NLS	 on	 PLGAHNPs	 of	 homogenous	 size	 below	 100	 nm	（68-70	 nm）.	 These	 targeting	
moieties	 layered	 on	 siRNA	 encapsulated	 PLGAHNPs	 enhanced	 the	 uptake	 of	 siRNA	
delivery	to	the	targeted	cells.	The	siRNA	duplex	was	prepared	using	T7	polymerase	and	
double	stranded	DNA	through	in vitro	transcription.	Incubation	of	the	siRNA	encapsulated	
PLGAHNPs	 functionalized	with	TAT	 and	PNA-NLS	（TAT-siRNA-PNA-PLGAHNPs-
siRNA）	with	cancer	cells	resulted	in	reduced	cell	proliferation.	A	downregulation	of	gene	
expression	 by	 90	％	was	 observed	 even	with	 a	 low	 concentration	 of	 siRNA.	She	 found	
complete	arrest	of	cell	division	which	was	mediated	by	downregulation	of	MYC	expression.
In	chapter	six,	she	presents	the	“Conclusion”	of	her	work.	In	this	thesis,	“Regime of gene 
silencing: Efficient siRNA delivery into cancer cells using nanocapsules”,	 the	 polymeric	
nanoparticle	mediated	siRNA	delivery	for	the	downregulation	of	protooncogene	in	cancer	
has	 been	 discussed.	 She	 presented	 the	 technique	 of	 synthesizing	 hollow	 PLGA	
nanoparticles	and	its	capacity	for	enhancing	drug	encapsulation	and	release	efficiency.	As	
these	 hollow	 PLGA	 nanoparticles	 have	 the	 potential	 of	 encapsulating	 the	 drug,	 she	
performed	experiments	on	siRNA	encapsulation	and	 its	release	efficiency.	These	siRNA	
encapsulated	 hollow	 PLGA	 nanoparticles	 used	 in	 siRNA	 delivery	 were	 able	 to	 reduce	
cancer	cell	proliferation	and	downregulate	the	MYC	proto-oncogene.	These	PLGAHNPs	
may	well	be	used	in	therapeutic	applications	as	ideal	nanocapsules	for	drug	delivery,	gene	
delivery	and	protein	delivery	in	the	future.
【審査結果】Summary and decision
The	doctoral	thesis	entitled	“Regime of gene silencing: Efficient siRNA delivery into cancer 
cells using nanocapsules”	 focuses	 on	 the	 development	 of	 hollow	 polymer	 nanoparticles	 to	
encapsulate	 SiRNA	 to	 deliver	 into	 cancer	 cells	 for	 gene	 therapy.	 For	 this,	 Archana	
Raichur	developed	a	novel	layer	by	layer	technique	for	safe	delivery	of	SiRNA,	first	she	
incorporated	 SiRNA	 into	 hollow	 PLGA	 polymer	 cages	 and	 then	 she	 used	 the	 LBL	
technique	to	coat	cell	penetrating	peptide	（CPP）	TAT	peptide	and	peptide	nucleic	acid-	
nucleolus	localizing	signal	（PNA-NLS）	for	targeted	deliver	of	SiRNA.
The	results	shown	in	the	thesis	are	outstanding	from	an	 international	point	of	view	and	
the	significant	points	in	the	present	study	are	summarized	below;
（1）	A	 very	 simple	 technique	 has	 been	 developed	 to	 synthesize	 hollow	 PLGA	
nanoparticles.
（2）	Hollow	PLGA	nanoparticles	have	been	used	to	encapsulate	SiRNA	for	gene	delivery.	
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Approximately	99％	encapsulation	efficiency	of	SiRNA	was	achieved	by	this	method.
（3）	New	 LBL	 technique	 was	 developed	 to	 coat	 on	 polymer	 hollow	 nanoparticles;	 Cell	
Penetrating	Peptide	and	peptide	nucleic	acid-	nucleolus	localizing	signal	（PNA-NLS）	
so	that	the	SiRNA	can	be	delivered	to	the	target.
（4）	It	 has	 been	 found	 that	 the	 developed	 system	 could	 suppress	 the	 gene	 expression,	
which	is	the	cause	of	the	cancer,	by	90％ .	The	result	is	remarkable.
Archana	 Raichur	 has	 published	 two	 first-authoring	 papers	 in	 international	 journals;	
Materials	Research	Express	and	NanoWorld	Journal.	She	won	the	best	presentation	award	
for	her	work	in	an	international	seminar	in	USA.	Judging	by	the	quality	of	the	research	
results	shown	in	the	thesis,	we	can	assure	that	the	new	drug	can	be	a	great	achievement	to	
fight	 against	 the	 cancer.	 In	 conclusion,	 the	 quality	 of	 the	 present	 study	 and	 thesis	 is	
considered	 to	 be	 very	 high	 by	 international	 standards	 and	 therefore	 the	 thesis	 can	 be	
accepted	for	awarding	a	doctoral	degree	to	Archana	Raichur.
02_東洋博士学位論文58-本文.indd   9 2016/01/29   11:52:29
